DouglasG.DayMD

PubMed

• 78 citations
  Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical Trial
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;American Journal of Ophthalmology. 2017 Mar 1
• 31 citations
  Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomis...
  Douglas G. Day, Thomas R Walters, Gail F. Schwartz, Thomas K Mundorf, Charlie Liu, Rhett M. Schiffman, Marina Bejanian> ;The British Journal of Ophthalmology. 2013 Aug 1
• 21 citations
  Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension.
  Douglas G Day, David A Hollander> ;Current Medical Research and Opinion. 2008 Apr 9
• 25 citations
  Mean intraocular pressure and progression based on corneal thickness in primary open-angle glaucoma.
  William C. Stewart, Douglas G. Day, Jessica N. Jenkins, Carla L. Passmore, Jeanette A. Stewart> ;Journal of Ocular Pharmacology and Therapeutics. 2006 Feb 27
• 24 citations
  A persistency and economic analysis of latanoprost, bimatoprost, or beta-blockers in patients with open-angle glaucoma or ocular hypertension.
  Douglas G. Day, Paul N. Schacknow, Elizabeth D. Sharpe, John C. Ellyn, John C. Kulze, Anisa B. Threlkeld, Evan D. Jones, Reay H. Brown, Jessica N. Jenkins, William C. ...> ;Journal of Ocular Pharmacology and Therapeutics. 2004 Oct 21
• 15 citations
  Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hy...
  Douglas G. Day, Paul N. Schacknow, Martin Wand, Elizabeth D. Sharpe, Jeanette A. Stewart, Jessica N. Leech, William C. Stewart> ;American Journal of Ophthalmology. 2003 Feb 1
• 10 citations
  An economic analysis of switching to latanoprost from a beta-blocker or adding brimonidine or latanoprost to a beta-blocker in open-angle glaucoma or ocular hypertension.
  William C. Stewart, BS Jessica Leech, Elizabeth D. Sharpe, John C. Kulze, John C. Ellyn, Douglas G. Day> ;The American Journal of Managed Care. 2002 Aug 1
• 4 citations
  Canalicular obliteration from toxic epidermal necrolysis.
  Alan B. Leahey, Allan E. Wulc, Douglas G. Day, Marie Uberti-Benz, James A. Katowitz> ;American Journal of Ophthalmology. 1991 Oct 1
• Join now to see all